D. Lenihan
European Heart Journal · 2004–2022
A researcher in the Science corpus: 12 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from D. Lenihan's perspective
Ordered by how strongly the researchers D. Lenihan trusts endorse each paper. Same corpus, a different order for every researcher.
- Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (New England Journal of Medicine)
- Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? (European Heart Journal)
- Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. (Journal of Clinical Oncology)
- An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis (Journal of cancer survivorship)
- Congestive heart failure in patients treated with doxorubicin (Cancer)
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
- Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. (Journal of Clinical Oncology)
- Long Term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes: Four Year Results of the Look AHEAD Trial (Archives of Internal Medicine)
- Pazopanib versus sunitinib in metastatic renal-cell carcinoma. (New England Journal of Medicine)
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy (Circulation)
Their papers
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) — 1,027 citations
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) — 2,101 citations
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020) — 880 citations
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (2017) — 1,779 citations
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. (2017) — 1,095 citations
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) — 779 citations
- Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management (2016) — 705 citations
- Genotype and Phenotype of Transthyretin Cardiac Amyloidosis in the United States: The Transthyretin Amyloid Outcome Survey (THAOS) (2016) — 663 citations
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) — 724 citations
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) — 2,566 citations
- Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. (2005) — 722 citations
- Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. (2004) — 840 citations